1.
J Korean Med Sci
; 36(15): e113, 2021 04 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33876590
2.
J Cardiovasc Electrophysiol
; 32(3): 878-879, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33522637
3.
J Allergy Clin Immunol
; 146(6): 1457, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33019963
4.
5.
Cardiovasc Hematol Agents Med Chem
; 12(1): 9-13, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25470148
RESUMO
Novel oral anticoagulants (NOACs) have been developed as alternatives for vitamin K antagonists (VKAs) for the prevention of thromboembolic events in patients with a variety of medical conditions. In this review, we summarize the current data on NOACs safety and efficacy compared to VKAs and in specific patients' groups including heart valve replacement, venous thromboembolism, advanced renal failure and the elderly.